Manchester Capital Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Manchester Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$26.2 - $36.08 $78 - $108	-3 Reduced 11.11%	24 $0
Q1 2022 May 09, 2022	SELL	$39.62 - $69.97 $8,993 - $15,883	-227 Reduced 89.37%	27 $1,000
Q3 2021 Nov 12, 2021	BUY	$58.38 - $84.96 $13,252 - $19,285	227 Added 840.74%	254 $16,000
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $1,678 - $2,438	27 New	27 $2,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Manchester Capital Management LLC with notifications on news.